
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
---|---|---|---|---|---|---|
09/30/2025 | Q3 | $309.1M | -- | -- | $1.49 | -- |
08/08/2025 | Q2 | $327.2M | -- | -- | $1.63 | -- |
04/30/2025 | Q1 | $296.6M | $290M | $0.69 | $1.30 | -$0.61 |
02/17/2025 | Q4 | $323.3M | $328.9M | $0.35 | $1.37 | -$1.02 |
10/31/2024 | Q3 | $319.4M | $315.8M | $1.09 | $1.44 | -$0.35 |
08/08/2024 | Q2 | $327M | $331M | $1.45 | $1.72 | -$0.27 |
05/03/2024 | Q1 | $310.5M | $311M | $1.49 | $1.42 | $0.07 |
02/22/2024 | Q4 | $310M | $311.4M | $1.64 | $1.25 | $0.39 |
10/31/2023 | Q3 | -- | -- | $1.21 | $1.15 | $0.06 |
08/04/2023 | Q2 | -- | -- | $1.68 | $1.16 | $0.52 |
04/28/2023 | Q1 | -- | -- | $1.30 | $0.84 | $0.46 |
02/23/2023 | Q4 | -- | -- | $1.27 | $1.21 | $0.06 |
10/27/2022 | Q3 | -- | -- | $0.83 | $1.10 | -$0.27 |
08/09/2022 | Q2 | -- | -- | $0.89 | $0.87 | $0.03 |
04/28/2022 | Q1 | -- | -- | $0.55 | $0.83 | -$0.28 |
02/24/2022 | Q4 | -- | -- | $0.42 | $0.63 | -$0.21 |
11/02/2021 | Q3 | -- | -- | $1.14 | $0.86 | $0.28 |
08/03/2021 | Q2 | -- | -- | $0.51 | $0.97 | -$0.46 |
05/04/2021 | Q1 | -- | -- | $1.37 | $0.60 | $0.77 |
02/25/2021 | Q4 | -- | -- | $0.13 | $0.50 | -$0.37 |
10/29/2020 | Q3 | -- | -- | $0.63 | $0.41 | $0.22 |
07/30/2020 | Q2 | -- | -- | $0.77 | $0.25 | $0.52 |
05/06/2020 | Q1 | -- | -- | $0.28 | $0.56 | -$0.28 |
02/20/2020 | Q4 | -- | -- | $0.59 | $0.61 | -$0.02 |
10/30/2019 | Q3 | -- | -- | $0.79 | $0.45 | $0.35 |
07/31/2019 | Q2 | -- | -- | $0.81 | $0.79 | $0.03 |
04/30/2019 | Q1 | -- | -- | $0.29 | $0.40 | -$0.11 |
02/21/2019 | Q4 | -- | -- | $0.42 | $0.48 | -$0.06 |
10/24/2018 | Q3 | -- | -- | $0.52 | -- | -- |
07/25/2018 | Q2 | -- | -- | $0.69 | -- | -- |
04/23/2018 | Q1 | -- | -- | $0.18 | -- | -- |
02/22/2018 | Q4 | -- | -- | -$0.18 | -- | -- |
11/02/2017 | Q3 | -- | -- | $0.20 | -- | -- |
08/02/2017 | Q2 | -- | -- | -$0.15 | -- | -- |
04/24/2017 | Q1 | -- | -- | -$0.22 | -- | -- |
02/23/2017 | Q4 | -- | -- | $0.85 | -- | -- |
10/25/2016 | Q3 | -- | -- | $0.64 | -- | -- |
07/26/2016 | Q2 | -- | -- | $0.85 | -- | -- |
04/25/2016 | Q1 | -- | -- | $0.25 | -- | -- |
02/23/2016 | Q4 | -- | -- | $0.73 | -- | -- |
10/27/2015 | Q3 | -- | -- | -$0.05 | -- | -- |
Tennant reported $290M worth of top line sales in its most recent quarter.
Tennant announced earnings per share of $0.69 which represents a miss of analyst forecast a $1.30 per share.
Tennant reported $120M that represents $6.33 per share over the last quarter.
Tennant's earnings are forecast to grow from $4.38 per share to $6.42 per share next year representing an increase of 33.11%.
Tennant's next earnings date is August 8, 2025.
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.